Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What are the anticoagulation recommendations for the Mitroflow Aortic Pericardial Heart Valve?

0
Posted

What are the anticoagulation recommendations for the Mitroflow Aortic Pericardial Heart Valve?

0

Extensive published data suggests that some form of anticoagulation therapy may be beneficial after bioprosthetic cardiac valve replacement in order to reduce the risk of thromboembolic phenomena. In general, for bioprostheses, consideration should be given to anticoagulation therapy for 30 to 60 days after aortic replacement. For patients with moderate to severe atrial enlargement, atrial fibrillation, left atrial thrombus, left atrial wall calcification or other atrial wall abnormalties, or a prior history of thromboembolic events, consideration should be given to prescribing indefinite anticoagulation therapy.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.